IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER
Clear-cell Metastatic Renal Cell Carcinoma
Celldex Therapeuticsmonoclonal_antibodyPhase 1Dormant
C
38/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 23/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Clear-cell Metastatic Renal Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
gw786034 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 4 | BBB |
Tak-228 Millennium Pharmaceuticals, Inc. | Phase 2 | B |
Serabelisib Millennium Pharmaceuticals, Inc. | Phase 2 | B |
RADIUM RA-223 Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Phase 1/2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →